COVID-19 Detection Kits Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Deployment, End User, Mode, Stage

Description

The global COVID-19 Detection Kits Market is projected to grow from $5.4 billion in 2025 to $3.4 billion by 2035, at a compound annual growth rate (CAGR) of -4.6%. The COVID-19 Detection Kits Market is moderately consolidated, with PCR-based kits accounting for the largest share due to their high diagnostic accuracy and continued use in confirmatory testing, while rapid antigen kits remain widely adopted for decentralized and point-of-care screening. Demand is increasingly supported by respiratory disease surveillance, multiplex molecular diagnostics, and preparedness for future infectious disease outbreaks. The market is characterized by continuous innovation in RT-PCR, isothermal amplification, and rapid immunoassay technologies, alongside the integration of automated laboratory workflows and digital reporting systems. Manufacturers are also expanding multiplex assays capable of detecting multiple respiratory pathogens using a single sample. For instance, in August 2025, Roche received U.S. FDA 510(k) clearance for its cobas Respiratory 4-flex molecular assay, which simultaneously detects and differentiates SARS-CoV-2, Influenza A, Influenza B, and RSV using its TAGS technology, strengthening the transition from standalone COVID-19 testing to comprehensive respiratory diagnostics and reinforcing innovation in the molecular diagnostics market.

Based on Type, the PCR-based Kits segment dominated the COVID-19 Detection Kits Market in 2025, owing to its superior diagnostic accuracy, high sensitivity, and global recognition as the reference standard for SARS-CoV-2 detection. PCR-based kits remain extensively used across hospitals, diagnostic laboratories, and public health laboratories for confirmatory diagnosis, surveillance, and variant monitoring. Their ability to detect low viral loads, support multiplex testing, and comply with regulatory guidelines has sustained demand despite declining routine testing volumes. Continuous adoption in clinical diagnostics, infectious disease surveillance, and preparedness for emerging respiratory pathogens further reinforces the segment's dominant position across developed and developing healthcare systems.

Market Segmentation
Type	PCR-based Kits, Antigen-based Kits, Antibody-based Kits, Isothermal Amplification Kits, CRISPR-based Kits, Others
Product	Test Strips, Reagents, Swabs, Control Kits, Buffers, Others
Technology	RT-PCR, LAMP, ELISA, Lateral Flow Assay, Next-Generation Sequencing, Others
Component	Sample Collection Kits, Detection Kits, Extraction Kits, Amplification Kits, Others
Application	Clinical Testing, Home Testing, Research Laboratories, Point of Care, Screening, Others
Deployment	On-site Testing, Remote Testing, Others
End User	Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Home Care, Public Health Labs, Others
Mode	Professional Use, Self-Testing, Others
Stage	Detection, Confirmation, Screening, Monitoring, Others

Based on Application, the Home Testing segment is expected to register the fastest growth during the forecast period, driven by increasing consumer preference for convenient, rapid, and self-administered diagnostic solutions. The widespread availability of rapid antigen self-test kits, growing awareness of home-based healthcare, and expanding retail and e-commerce distribution channels continue to support adoption. Government initiatives promoting decentralized testing, along with advancements in easy-to-use diagnostic formats and digital result reporting, are accelerating market growth. Home testing also reduces healthcare facility burden, enables timely isolation decisions, and supports ongoing monitoring of respiratory infectious diseases beyond the COVID-19 pandemic.

Geographical Overview

North America dominated the COVID-19 Detection Kits Market in 2025, supported by its advanced healthcare infrastructure, well-established molecular diagnostic laboratories, and strong public health surveillance systems. The United States accounted for the largest regional share due to continued investments in infectious disease preparedness, widespread adoption of RT-PCR and multiplex respiratory testing, and the presence of leading diagnostic manufacturers. Canada also contributes significantly through government-backed disease surveillance programs and laboratory modernization initiatives. Although routine COVID-19 testing volumes have declined, sustained demand for respiratory pathogen panels, hospital diagnostics, and outbreak preparedness continues to support the region's leadership.

Asia-Pacific is expected to register the fastest growth during the forecast period, driven by expanding healthcare infrastructure, increasing investments in molecular diagnostics, and strengthening infectious disease surveillance programs. China, India, and Japan are the key growth markets due to their large populations, expanding diagnostic laboratory networks, and rising adoption of rapid and molecular testing technologies. Government initiatives to improve pandemic preparedness, growing domestic manufacturing of diagnostic kits, and increasing integration of multiplex respiratory testing into routine clinical practice are further accelerating market expansion. Rising healthcare expenditure and improved access to advanced diagnostic technologies continue to create significant growth opportunities across the region.

Key Trends and Drivers

Increasing Adoption of Multiplex Respiratory Diagnostic Testing:

The COVID-19 detection kits market is evolving from standalone SARS-CoV-2 testing toward multiplex molecular diagnostics capable of detecting multiple respiratory pathogens, including influenza A/B and respiratory syncytial virus (RSV), through a single assay. Healthcare providers and diagnostic laboratories are increasingly adopting these solutions to improve clinical decision-making, reduce laboratory workload, and enhance testing efficiency during respiratory infection seasons. Continuous advancements in RT-PCR, isothermal amplification, and automated molecular platforms are further supporting this transition. The growing emphasis on integrated respiratory disease surveillance and pandemic preparedness is expected to sustain demand for advanced multiplex detection kits.

Growing Investments in Infectious Disease Surveillance and Pandemic Preparedness:

Governments, healthcare organizations, and public health agencies are increasing investments in infectious disease surveillance infrastructure and diagnostic preparedness to strengthen future outbreak response capabilities. The expansion of molecular diagnostic laboratories, strategic stockpiling of testing supplies, and modernization of public health laboratory networks are driving continued demand for COVID-19 detection kits and related diagnostic technologies. Rising adoption of decentralized testing, increasing awareness of early disease detection, and continuous funding for laboratory automation and genomic surveillance are further accelerating market growth while supporting long-term preparedness against emerging infectious diseases.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS10525

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by End User
2.6 Key Market Highlights by Component
2.7 Key Market Highlights by Mode
2.8 Key Market Highlights by Stage
2.9 Key Market Highlights by Deployment

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 PCR-based Kits
- 4.1.2 Antigen-based Kits
- 4.1.3 Antibody-based Kits
- 4.1.4 Isothermal Amplification Kits
- 4.1.5 CRISPR-based Kits
- 4.1.6 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Test Strips
- 4.2.2 Reagents
- 4.2.3 Swabs
- 4.2.4 Control Kits
- 4.2.5 Buffers
- 4.2.6 Others
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 RT-PCR
- 4.3.2 LAMP
- 4.3.3 ELISA
- 4.3.4 Lateral Flow Assay
- 4.3.5 Next-Generation Sequencing
- 4.3.6 Others
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Clinical Testing
- 4.4.2 Home Testing
- 4.4.3 Research Laboratories
- 4.4.4 Point of Care
- 4.4.5 Screening
- 4.4.6 Others
4.5 Market Size & Forecast by End User (2020-2035)
- 4.5.1 Hospitals
- 4.5.2 Diagnostic Laboratories
- 4.5.3 Academic and Research Institutes
- 4.5.4 Home Care
- 4.5.5 Public Health Labs
- 4.5.6 Others
4.6 Market Size & Forecast by Component (2020-2035)
- 4.6.1 Sample Collection Kits
- 4.6.2 Detection Kits
- 4.6.3 Extraction Kits
- 4.6.4 Amplification Kits
- 4.6.5 Others
4.7 Market Size & Forecast by Mode (2020-2035)
- 4.7.1 Professional Use
- 4.7.2 Self-Testing
- 4.7.3 Others
4.8 Market Size & Forecast by Stage (2020-2035)
- 4.8.1 Detection
- 4.8.2 Confirmation
- 4.8.3 Screening
- 4.8.4 Monitoring
- 4.8.5 Others
4.9 Market Size & Forecast by Deployment (2020-2035)
- 4.9.1 On-site Testing
- 4.9.2 Remote Testing
- 4.9.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Application
  - 5.2.1.5 End User
  - 5.2.1.6 Component
  - 5.2.1.7 Mode
  - 5.2.1.8 Stage
  - 5.2.1.9 Deployment
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Application
  - 5.2.2.5 End User
  - 5.2.2.6 Component
  - 5.2.2.7 Mode
  - 5.2.2.8 Stage
  - 5.2.2.9 Deployment
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Application
  - 5.2.3.5 End User
  - 5.2.3.6 Component
  - 5.2.3.7 Mode
  - 5.2.3.8 Stage
  - 5.2.3.9 Deployment
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Application
  - 5.3.1.5 End User
  - 5.3.1.6 Component
  - 5.3.1.7 Mode
  - 5.3.1.8 Stage
  - 5.3.1.9 Deployment
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Application
  - 5.3.2.5 End User
  - 5.3.2.6 Component
  - 5.3.2.7 Mode
  - 5.3.2.8 Stage
  - 5.3.2.9 Deployment
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Application
  - 5.3.3.5 End User
  - 5.3.3.6 Component
  - 5.3.3.7 Mode
  - 5.3.3.8 Stage
  - 5.3.3.9 Deployment
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Application
  - 5.4.1.5 End User
  - 5.4.1.6 Component
  - 5.4.1.7 Mode
  - 5.4.1.8 Stage
  - 5.4.1.9 Deployment
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Application
  - 5.4.2.5 End User
  - 5.4.2.6 Component
  - 5.4.2.7 Mode
  - 5.4.2.8 Stage
  - 5.4.2.9 Deployment
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Application
  - 5.4.3.5 End User
  - 5.4.3.6 Component
  - 5.4.3.7 Mode
  - 5.4.3.8 Stage
  - 5.4.3.9 Deployment
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Application
  - 5.4.4.5 End User
  - 5.4.4.6 Component
  - 5.4.4.7 Mode
  - 5.4.4.8 Stage
  - 5.4.4.9 Deployment
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Application
  - 5.4.5.5 End User
  - 5.4.5.6 Component
  - 5.4.5.7 Mode
  - 5.4.5.8 Stage
  - 5.4.5.9 Deployment
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Application
  - 5.4.6.5 End User
  - 5.4.6.6 Component
  - 5.4.6.7 Mode
  - 5.4.6.8 Stage
  - 5.4.6.9 Deployment
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Application
  - 5.4.7.5 End User
  - 5.4.7.6 Component
  - 5.4.7.7 Mode
  - 5.4.7.8 Stage
  - 5.4.7.9 Deployment
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Application
  - 5.5.1.5 End User
  - 5.5.1.6 Component
  - 5.5.1.7 Mode
  - 5.5.1.8 Stage
  - 5.5.1.9 Deployment
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Application
  - 5.5.2.5 End User
  - 5.5.2.6 Component
  - 5.5.2.7 Mode
  - 5.5.2.8 Stage
  - 5.5.2.9 Deployment
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Application
  - 5.5.3.5 End User
  - 5.5.3.6 Component
  - 5.5.3.7 Mode
  - 5.5.3.8 Stage
  - 5.5.3.9 Deployment
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Application
  - 5.5.4.5 End User
  - 5.5.4.6 Component
  - 5.5.4.7 Mode
  - 5.5.4.8 Stage
  - 5.5.4.9 Deployment
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Application
  - 5.5.5.5 End User
  - 5.5.5.6 Component
  - 5.5.5.7 Mode
  - 5.5.5.8 Stage
  - 5.5.5.9 Deployment
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Application
  - 5.5.6.5 End User
  - 5.5.6.6 Component
  - 5.5.6.7 Mode
  - 5.5.6.8 Stage
  - 5.5.6.9 Deployment
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Application
  - 5.6.1.5 End User
  - 5.6.1.6 Component
  - 5.6.1.7 Mode
  - 5.6.1.8 Stage
  - 5.6.1.9 Deployment
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Application
  - 5.6.2.5 End User
  - 5.6.2.6 Component
  - 5.6.2.7 Mode
  - 5.6.2.8 Stage
  - 5.6.2.9 Deployment
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Application
  - 5.6.3.5 End User
  - 5.6.3.6 Component
  - 5.6.3.7 Mode
  - 5.6.3.8 Stage
  - 5.6.3.9 Deployment
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Application
  - 5.6.4.5 End User
  - 5.6.4.6 Component
  - 5.6.4.7 Mode
  - 5.6.4.8 Stage
  - 5.6.4.9 Deployment
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Application
  - 5.6.5.5 End User
  - 5.6.5.6 Component
  - 5.6.5.7 Mode
  - 5.6.5.8 Stage
  - 5.6.5.9 Deployment

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Roche Diagnostics
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Abbott Laboratories
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Thermo Fisher Scientific
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Siemens Healthineers
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Becton Dickinson
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Bio-Rad Laboratories
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Qiagen
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Hologic
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 PerkinElmer
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Danaher Corporation
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 bioMerieux
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Cepheid
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Luminex Corporation
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Quidel Corporation
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 GenMark Diagnostics
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 OraSure Technologies
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 F. Hoffmann-La Roche
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Meridian Bioscience
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Seegene
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Tecan Group
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us